
Dialyte-AC
Popular Pharmaceuticals Ltd.
Acetate Formulation [Hemodialysis Solution] is a concentrated electrolyte solution that, after dilution according to dialysis machine specifications and more.
Acetate Formulation [Hemodialysis Solution] is a concentrated electrolyte solution that, after dilution according to dialysis machine specifications, is used to prepare the dialysate (bath) for hemodialysis treatment. It is indicated as part of the extracorporeal hemodialysis procedure to help correct fluid overload, electrolyte disturbances, and metabolic acidosis in patients with acute kidney injury or end-stage renal disease (ESRD) who require renal replacement therapy.
Acetate Formulation [Hemodialysis Solution] is intended for use only as a component of the hemodialysis procedure performed in a hospital or dialysis center; it is not a self-administered outpatient medicine.
Acetate Formulation [Hemodialysis Solution] is not dosed as a conventional medicine. It is diluted from concentrate to working dialysate strength strictly according to the dialysis machine manufacturer's proportioning instructions, and the composition, dialysate flow rate, and duration of each hemodialysis session are individualized by the treating nephrologist/dialysis team based on the patient's fluid status, electrolyte levels, acid-base balance, and overall clinical condition.
| Setting | General approach |
|---|---|
| Adult hemodialysis (chronic maintenance) | Typically 3-4 hour sessions, about 3 times weekly; dialysate composition and flow individualized by the nephrology team using Acetate Formulation [Hemodialysis Solution] diluted per machine specifications. |
| Acute kidney injury (hospital setting) | Session frequency, duration, and dialysate composition determined by the treating physician based on the severity of fluid, electrolyte, and acid-base derangement. |
| Renal/hepatic adjustment | Not applicable in the conventional sense, since this product is used specifically in patients with kidney failure; however, patients with significant hepatic impairment may have reduced ability to metabolize acetate to bicarbonate and require closer monitoring (see Precautions). |
See Precautions and Warnings for monitoring requirements.
Side effects associated with Acetate Formulation [Hemodialysis Solution] are generally related to the hemodialysis procedure and the acetate buffer itself:
Patients should report any unusual symptoms during dialysis to their dialysis care team immediately.
Acetate Formulation [Hemodialysis Solution] is contraindicated in patients with known hypersensitivity to any component of the solution. It must not be used outside a supervised hemodialysis setting — it is not a patient-self-administered product and must be used only under the direct supervision of trained dialysis/nephrology healthcare personnel with appropriate dialysis equipment.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.